Support Your Metabolism with Clinically-Studied Ingredients

Mitolyn — 6 plant-based nutrients to boost mitochondrial health, energy & natural fat burning.

★★★★★ 127,000+ customers · 90-day money-back guarantee

Dr. Daniel Murman, MD

Neurology Omaha, NE Male

NPI: 1982654125

Total Payments

$5,359

2024 Payments

$73.02

Companies

Transactions

Medicare Patients

2,317

Medicare Billing

$194,700

Payment Breakdown by Category

Travel$1,846 (34.4%)

Food & Beverage$1,281 (23.9%)

Consulting$1,181 (22.0%)

Research$942.00 (17.6%)

Education$109.89 (2.1%)

Payments by Nature

Nature of Payment	Amount	Transactions	Share
Travel and Lodging	$1,846	6	34.4%
Food and Beverage	$1,281	8	23.9%
Consulting Fee	$1,181	1	22.0%
Unspecified	$942.00	2	17.6%
Education	$109.89	3	2.1%

Payments by Type

General

$4,417

18 transactions

Research

$942.00

2 transactions

Top Paying Companies

Company	Total	Records	Latest Year
Biogen, Inc.	$1,425	5	$0 (2022)
Novartis Pharmaceuticals Corporation	$1,411	8	$0 (2017)
F. Hoffmann-La Roche AG	$1,359	3	$0 (2017)
Eli Lilly and Company	$942.00	2	$0 (2022)
Genentech USA, Inc.	$149.86	1	$0 (2022)
Eisai Inc.	$73.02	1	$0 (2024)

Payment History by Year

Year	Amount	Transactions	Top Company
2024	$73.02	1	Eisai Inc. ($73.02)
2022	$1,056	5	Eli Lilly and Company ($672.00)
2020	$1,461	3	Biogen, Inc. ($1,191)
2017	$2,770	11	Novartis Pharmaceuticals Corporation ($1,411)

All Payment Transactions

20 individual payment records from CMS Open Payments

Date	Company	Product	Nature	Form	Amount	Type
04/15/2024	Eisai Inc.	—	Food and Beverage	In-kind items and services	$73.02	General
12/01/2022	Genentech USA, Inc.	—	Food and Beverage	In-kind items and services	$149.86	General
11/30/2022	Biogen, Inc.	ADUHELM (Biological)	Food and Beverage	In-kind items and services	$133.95	General
Category: Neurology
04/14/2022	Eli Lilly and Company	—	—	In-kind items and services	$672.00	Research
Study: ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE -A4 STUDY
03/24/2022	Biogen, Inc.	—	Education	In-kind items and services	$51.00	General
03/24/2022	Biogen, Inc.	—	Education	In-kind items and services	$49.20	General
07/31/2020	Eli Lilly and Company	—	—	In-kind items and services	$270.00	Research
Study: ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE -A4 STUDY
07/06/2020	Biogen, Inc.	—	Consulting Fee	Cash or cash equivalent	$1,181.00	General
04/23/2020	Biogen, Inc.	—	Education	In-kind items and services	$9.69	General
11/17/2017	Novartis Pharmaceuticals Corporation	CNP520 (Drug)	Food and Beverage	In-kind items and services	$102.52	General
11/16/2017	Novartis Pharmaceuticals Corporation	CNP520 (Drug)	Travel and Lodging	In-kind items and services	$465.92	General
11/16/2017	Novartis Pharmaceuticals Corporation	CNP520 (Drug)	Food and Beverage	In-kind items and services	$124.67	General
11/16/2017	Novartis Pharmaceuticals Corporation	CNP520 (Drug)	Food and Beverage	In-kind items and services	$114.99	General
11/16/2017	Novartis Pharmaceuticals Corporation	CNP520 (Drug)	Travel and Lodging	Cash or cash equivalent	$57.02	General
11/16/2017	Novartis Pharmaceuticals Corporation	CNP520 (Drug)	Travel and Lodging	In-kind items and services	$18.00	General
11/15/2017	NOVARTIS PHARMACEUTICALS CORPORATION	—	Travel and Lodging	In-kind items and services	$408.00	General
11/15/2017	Novartis Pharmaceuticals Corporation	CNP520 (Drug)	Food and Beverage	In-kind items and services	$119.71	General
07/12/2017	F. Hoffmann-La Roche AG	Non-Covered Product (Drug)	Travel and Lodging	In-kind items and services	$498.85	General
Category: None
07/12/2017	F. Hoffmann-La Roche AG	Non-Covered Product (Drug)	Food and Beverage	In-kind items and services	$462.00	General
Category: None
07/12/2017	F. Hoffmann-La Roche AG	Non-Covered Product (Drug)	Travel and Lodging	In-kind items and services	$398.00	General
Category: None

Research Studies & Clinical Trials

Study Name	Company	Amount	Records
ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE -A4 STUDY	Eli Lilly and Company	$942.00	2

Medicare Billing by Year

Year	Procedures	Beneficiaries	Services	Submitted	Medicare Paid
2023	4	569	719	$186,689	$46,625
2022	4	634	744	$213,507	$54,909
2021	4	664	744	$222,765	$59,859
2020	6	450	471	$167,220	$33,307

Total Patients

2,317

Total Services

2,678

Medicare Billing

$194,700

Procedure Codes

All Medicare Procedures & Services

32 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS	Description	Setting	Year	Patients	Services	Charges	Medicare Paid	Ratio
99215	Established patient office or other outpatient visit, 40-54 minutes	Facility	2023	133	144	$50,400	$12,968	25.7%
99215	Established patient office or other outpatient visit, 40-54 minutes	Office	2023	137	145	$50,750	$12,342	24.3%
99205	New patient office or other outpatient visit, 60-74 minutes	Facility	2023	75	75	$36,000	$8,870	24.6%
99205	New patient office or other outpatient visit, 60-74 minutes	Office	2023	49	49	$23,520	$5,351	22.8%
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	Facility	2023	103	185	$14,523	$4,110	28.3%
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	Office	2023	60	109	$8,557	$2,337	27.3%
99214	Established patient office or other outpatient visit, 30-39 minutes	Office	2023	12	12	$2,940	$647.10	22.0%
99215	Established patient office or other outpatient visit, 40-54 minutes	Facility	2022	180	195	$69,370	$17,856	25.7%
99215	Established patient office or other outpatient visit, 40-54 minutes	Office	2022	170	180	$64,160	$16,701	26.0%
99205	New patient office or other outpatient visit, 60-74 minutes	Facility	2022	62	62	$30,500	$7,461	24.5%
99205	New patient office or other outpatient visit, 60-74 minutes	Office	2022	38	38	$18,580	$4,741	25.5%
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	Facility	2022	84	139	$10,912	$3,020	27.7%
99214	Established patient office or other outpatient visit, 30-39 minutes	Office	2022	29	29	$7,275	$1,900	26.1%
99214	Established patient office or other outpatient visit, 30-39 minutes	Facility	2022	27	28	$6,980	$1,616	23.2%
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	Office	2022	44	73	$5,731	$1,612	28.1%
99215	Established patient outpatient visit, total time 40-54 minutes	Facility	2021	171	186	$66,960	$18,708	27.9%
99215	Established patient outpatient visit, total time 40-54 minutes	Office	2021	167	178	$64,080	$16,981	26.5%
99205	New patient outpatient visit, total time 60-74 minutes	Facility	2021	79	79	$39,500	$10,273	26.0%
99205	New patient outpatient visit, total time 60-74 minutes	Office	2021	49	49	$24,500	$6,149	25.1%
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	Facility	2021	99	132	$10,362	$3,194	30.8%
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	Office	2021	56	75	$5,888	$1,801	30.6%
99214	Established patient outpatient visit, total time 30-39 minutes	Facility	2021	23	25	$6,375	$1,686	26.4%
99214	Established patient outpatient visit, total time 30-39 minutes	Office	2021	20	20	$5,100	$1,066	20.9%
99215	Established patient office or other outpatient, visit typically 40 minutes	Facility	2020	114	127	$45,720	$9,034	19.8%
99215	Established patient office or other outpatient, visit typically 40 minutes	Office	2020	117	122	$43,920	$8,398	19.1%

1 2 »

About Dr. Daniel Murman, MD

Dr. Daniel Murman, MD is a Neurology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982654125.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Murman, MD has received a total of $5,359 in payments from pharmaceutical and medical device companies, with $73.02 received in 2024. These payments were reported across 20 transactions from 6 companies. The most common payment nature is "Travel and Lodging" ($1,846).

As a Medicare-enrolled provider, Murman has provided services to 2,317 Medicare beneficiaries, totaling 2,678 services with total Medicare billing of $194,700. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.

16,000 Woodworking Plans

Step-by-step blueprints for any project. Beginner to expert.

Detailed schematics Cutting lists & materials Lifetime access — $67

★★★★★ 60-day guarantee

Get Instant Access

Practice Information

Specialty Neurology
Location Omaha, NE
Active Since 05/10/2006
Last Updated 06/28/2011
Taxonomy Code 2084N0400X
Entity Type Individual
NPI Number 1982654125

Products in Payments

Non-Covered Product (Drug) $1,359
CNP520 (Drug) $1,003
ADUHELM (Biological) $133.95

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.